menu ☰
menu ˟

Alzheimer's Research & Therapy

Title Added Edit View
In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology 27 Mar 2020 edit view
Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer’s disease after traumatic brain injury 27 Mar 2020 edit view
Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer’s disease after a 27-month delay interval 24 Mar 2020 edit view
The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions: implications for cutoffs regarding cognitive impairment 24 Mar 2020 edit view
Effects of low- and high-intensity physical exercise on physical and cognitive function in older persons with dementia: a randomized controlled trial 19 Mar 2020 edit view
Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase 19 Mar 2020 edit view
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification 17 Mar 2020 edit view
A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer’s disease 16 Mar 2020 edit view
Comparison of Instrumental Activities of Daily Living assessment by face-to-face or telephone interviews: a randomized, crossover study 13 Mar 2020 edit view
Functional neuroimaging in subjective cognitive decline: current status and a research path forward 09 Mar 2020 edit view
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease 04 Mar 2020 edit view
The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease 02 Mar 2020 edit view
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg 28 Feb 2020 edit view
Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases 13 Feb 2020 edit view
University College London/University of Gothenburg PhD course “Biomarkers in neurodegenerative diseases” 2019—course organisation 04 Feb 2020 edit view
We need to think about data governance for dementia research in a digital era 31 Jan 2020 edit view
Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer’s disease 22 Jan 2020 edit view
PET imaging of mGluR5 in Alzheimer’s disease 18 Jan 2020 edit view
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 31 Dec 2019 edit view
Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer’s disease associated with obesity, metabolic syndrome, and type 2 diabetes 31 Dec 2019 edit view
APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain 30 Dec 2019 edit view
High occurrence of transportation and logistics occupations among vascular dementia patients: an observational study 27 Dec 2019 edit view
Focused ultrasound-induced blood-brain barrier opening improves adult hippocampal neurogenesis and cognitive function in a cholinergic degeneration dementia rat model 27 Dec 2019 edit view
Pay attention to the basal ganglia: a volumetric study in early dementia with Lewy bodies 21 Dec 2019 edit view
Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice 17 Dec 2019 edit view